NOOR, M. H. (2025) “Open-Label Randomized Trial of High-Dose Rifampicin to Shorten Treatment for Drug-Sensitive Pulmonary TB (Hi-Dori-3)”, Annals of Pakistan Medical & Allied Professionals, 1(7, October), pp. 7–11. doi: 10.53350/Annalspakmed.1.7.7.